People · Operator
Named in public records as an officer, director or promoter · active 2007–2022 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vir Biotechnology, Inc. | — | Biotechnology | Series D+ | $348.4M | $1.3B | 2018 |
| Linkedin Corp | — | Other Technology | Series D+ | $237.6M | $3.8B | 2007 |
| TenSixty Biosciences, Inc. | — | Biotechnology | Series A | $7.2M | $93.6M | 2022 |
Dipchand Nishar at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Dipchand Nishar on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Nelsen | 1 | 22 |
| Kristina Burow | 1 | 16 |
| Reid Hoffman | 1 | 10 |
| Robert More | 1 | 7 |
| Vicki Sato | 1 | 6 |
| A. George Battle | 1 | 5 |
| Sara Choi | 1 | 5 |
| Thomas Daniel | 1 | 4 |
| Saira Ramasastry | 1 | 4 |
| George Scangos | 1 | 4 |
| Leslie Kilgore | 1 | 4 |
| Robert Perez | 1 | 3 |
| Michael Gamson | 1 | 3 |
| Michael Kamarck | 1 | 2 |
| Philip Sharp | 1 | 2 |
| Jay Parrish | 1 | 2 |
| David Henke | 1 | 2 |
| Erika Rottenberg | 1 | 2 |
| David J. Henke | 1 | 2 |
| James Kevin Scott | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.